Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma

Sorafenib demonstrated a survival benefit in the treatment of advanced hepatocellular carcinoma (HCC) in phase III trials. However, almost all the patients included in those trials exhibited well-preserved liver function (Child-Pugh A). The aim of this study was to describe our experience with soraf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: DA FONSECA, LEONARDO GOMES, BARROSO-SOUSA, ROMUALDO, BENTO, AFONSO DA SILVA ALVES, BLANCO, BRUNA PACCOLA, VALENTE, GABRIEL LUIS, PFIFFER, TULIO EDUARDO FLESCH, HOFF, PAULO MARCELO, SABBAGA, JORGE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487071/
https://ncbi.nlm.nih.gov/pubmed/26171182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados